Diabetes

Top Story

STAMPEDE: Sustained glycemic benefit observed 5 years after gastric bypass in type 2 diabetes, obesity

STAMPEDE: Sustained glycemic benefit observed 5 years after gastric bypass in type 2 diabetes, obesity
February 21, 2017

Patients with type 2 diabetes and mild to moderate obesity who underwent Roux-en-Y gastric bypass or sleeve gastrectomy saw sustained improvements in HbA1c, body weight, lipid levels and quality of life 5 years after surgery that were superior to medical therapy alone, according to results from the STAMPEDE trial.

“Five years is a long time for follow-up, and that is one of the distinguishing features of this study,” Sangeeta Kashyap, MD, of the department of endocrinology, diabetes and metabolism at Cleveland Clinic, told Endocrine Today. “What is remarkable is patients who underwent bariatric surgery had far better glycemic control, with less use of insulin and medications. Almost 90% of patients did not need insulin after surgery. These patients had better triglycerides, higher HDL cholesterol levels, lower C-reactive protein levels, and maintained almost 20% total body weight loss. And, overall, based on their self-reported questionnaires, they had better quality of life.”

In the Journals

Benefits of statin therapy outweigh diabetes risk

February 20, 2017
In a commentary published in The American Journal of Medicine, experts wrote that the CV benefits of statins outweigh any diabetes-related risk they may present
In the Journals

DAPT, aspirin monotherapy confer similar outcomes in patients with diabetes after CABG

February 17, 2017
New data suggest that use of dual antiplatelet therapy may not be clinically warranted in patients with diabetes post-CABG. According to data published in the Journal
In the Journals

Low socioeconomic status as significant a risk factor for mortality as diabetes, high blood pressure, obesity

February 17, 2017
To reduce the risk of mortality, local and global health policies should include efforts to address low socioeconomic status as a contributor to poor health, according
Perspective
Commentary

2016: An active, exciting year in cardiology

Cardiology Today, January 2017
Carl J. Pepine, MD, MACC
The past year has been a very active and exciting one in CVD and CV medicine. We have had major successes on several…
More »
Video
Meeting News Coverage

VIDEO: Diabetes may be risk equivalent for PAD, CAS

April 3, 2016
More »
Featured
American Heart Association Scientific Sessions

American Heart Association Scientific Sessions

Video
Meeting News Coverage

VIDEO: Positive CV outcomes with SGLT2 inhibitors mark ‘an exciting time’

January 7, 2016
More »
In the JournalsPerspective

Industry sponsorship more often associated with positive results in nutrition studies

October 31, 2016
Data published in JAMA Internal Medicine suggest that industry-sponsored nutrition research is more likely to draw outcomes that are more favorable…

In the Journals Plus

PCI success, complications similar in patients with, without diabetes

October 25, 2016
Patients with diabetes who underwent percutaneous coronary intervention represented nearly half of those undergoing the surgery in a U.S. cohort

In the Journals

Quitting smoking at working age may reduce CVD risk to same level as never-smokers

October 24, 2016
Among the working-age population in Finland, past or present smoking appears to have clinically minor significance on individual CVD risk factors…

Meeting News Coverage

Dapagliflozin, potassium-sparing diuretics lower HbA1c in type 2 diabetes

October 19, 2016
NEW ORLEANS — The use of dapagliflozin in combination with potassium-sparing diuretics significantly lowered HbA1c, body weight and systolic…

Meeting News Coverage

Visceral adipose tissue holds clues to cardiometabolic risk

October 14, 2016
BOSTON — Intra-abdominal visceral fat plays a causal role in the development of almost all components of metabolic syndrome, irrespective of a…

Meeting News Coverage

Bariatric surgery ‘powerful’ tool for understanding biology of obesity

October 11, 2016
BOSTON — A physiological regulation of energy balance drives most obesogenic behavior, and bariatric surgery is likely to best option to…

Meeting News CoveragePerspective

Insulin therapy in 2017: More options, but greater costs may limit use

October 10, 2016
BOSTON — Several new insulin therapies are anticipated for patients with diabetes in 2017; however, for many, cost may put the latest options…

Meeting News Coverage

Review of CV outcome trials for diabetes drugs shows neutral or positive results

October 7, 2016
BOSTON — At the Cardiometabolic Health Conference, Jay S. Skyler, MD, MACP, from the division of endocrinology, diabetes and metabolism and…

Meeting News Coverage

For SGLT2 inhibitors, big benefits come with some trade-offs

October 7, 2016
BOSTON — The overall profile of sodium-glucose cotransporter 2 inhibitors suggests they are a reliable, second-line therapy choice for adults…

Meeting News Coverage

Lower BP confers better outcomes, even in patients with diabetes

October 7, 2016
BOSTON — The SPRINT trial and several meta-analyses suggest that more intensive reduction of systolic BP leads to better CV outcomes, but

More Headlines »
Advertisement
Advertisement